Signos

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Signos sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials none currently recruiting upper quartile by trial count

Signos: 3 sponsored US clinical trials, none currently recruiting.

Signos sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most-studied condition in this pipeline is Weight Loss, with 3 trials.

Upper-quartile sponsor footprint

Signos sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

3 total, page 1 of 1

ACTIVE NOT RECRUITING NA

Using Signos mHealth Platform in Adults for Weight Management

NCT06214221
ACTIVE NOT RECRUITING NA

Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

NCT05874635
ACTIVE NOT RECRUITING NA

Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform

NCT05121844

Therapeutic Areas

Weight Loss 3
Metabolic Syndrome 3
Metabolic Glucose Disorders 2
Central Obesity 2
Glucose Intolerance 2
Diabetes Mellitus, Type 2 1
PreDiabetes 1
Insulin Resistance 1
Overweight and Obesity 1

How the Signos archive is shaped

3 indexed studies, none listed as recruiting (0% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Weight Loss (3 trials), 8 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Signos: archived-pipeline peers nationwide

Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Signos sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Signos10xBio22nd Century GroupAA SecordAAADRS Clinical Research Center23andMe3-C Institute for Social Development3 Waves Wellness3EO Health
Signos sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Signos sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Signos page

3 registered trials is a research-attention snapshot, not an endorsement of Signos or any single study.

  • None of Signos's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Weight Loss is the condition Signos studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Weight Loss trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Signos pipeline card: 3 registered trials from official public datasets.Report a data error.